
The EU PFAS universal restriction after its revised proposal
The EU PFAS Universal Restriction After Its Revised Proposal
Europe’s Universal PFAS Restriction Enters a Decisive Stage
The European Union's plan to introduce a broad restriction on per- and polyfluoroalkyl substances (PFAS) has moved into a critical stage following the revision of the original proposal.
The initiative is one of the most ambitious chemical-regulatory actions being considered under the EU's REACH Regulation. Rather than applying an identical prohibition to every PFAS use, the revised approach is increasingly focused on combining a broad restriction with targeted derogations, transition periods and conditions for uses where alternatives are not yet available.
The original restriction proposal was submitted to the European Chemicals Agency (ECHA) in January 2023 by authorities from Denmark, Germany, the Netherlands, Norway and Sweden. Following a major public consultation that generated more than 5,600 scientific and technical comments, the submitting authorities revised the proposal.
PFAS are used across a wide range of industrial and consumer applications, making an EU-wide restriction particularly complex.
What Changed in the Revised PFAS Proposal?
The revised proposal published in August 2025 did not simply repeat the original concept.
The five submitting authorities evaluated thousands of comments received during the initial consultation and expanded their assessment to cover eight sectors that were not specifically identified in the original proposal.
These included:
Printing applications
Sealing applications
Machinery applications
Additional medical applications
Military applications
Explosives
Technical textiles
Broader industrial applications, including solvents and catalysts
The revised work also examined alternatives to a straightforward ban, including regulatory options that would allow some PFAS uses to continue under controlled conditions.
This is important because the EU's approach is evolving from a simple question of “ban or no ban” toward a more detailed assessment of where PFAS can be replaced, where transition periods are necessary and where continued use may be considered critical.
ECHA Supports EU-Wide Action With Targeted Derogations
In March 2026, ECHA's Risk Assessment Committee (RAC) adopted its final scientific opinion on the PFAS restriction proposal.
RAC concluded that PFAS pose risks to people and the environment that justify EU-wide restriction.
At the same time, ECHA's Committee for Socio-Economic Analysis (SEAC) supported an EU-wide restriction subject to specific derogations in its draft opinion. The committees also recommended that restrictions be complemented by measures designed to reduce PFAS emissions.
This represents a significant development because the scientific evaluation has moved beyond simply establishing whether PFAS present a regulatory concern.
The next question is increasingly about how the restriction should work in practice.
The Proposal Is Not Yet an EU-Wide Ban
It is important to distinguish between the PFAS restriction proposal and a final EU law.
The revised proposal and ECHA's committee opinions do not themselves create a new blanket prohibition.
After ECHA completes its scientific evaluation, the opinions are submitted to the European Commission. The Commission will then develop a restriction proposal for discussion and voting by the EU Member States through the REACH Committee.
The Commission has indicated that ECHA's final scientific assessment is expected by the end of 2026, after which the Commission will present its restriction proposal.
This means the final scope, exemptions, transition periods and compliance conditions are not yet fully settled.
Why Derogations Are Becoming Central
PFAS are used in applications where their combination of chemical, thermal and physical properties can be difficult to replace.
For some industrial applications, alternatives may exist but may not yet provide the required performance, safety or economic characteristics.
This is why the revised regulatory approach is examining targeted derogations.
A derogation can allow a particular PFAS use to continue when regulators determine that an immediate prohibition would create disproportionate difficulties or that suitable alternatives are not currently available.
However, a derogation does not necessarily mean permanent approval.
The regulatory framework can instead provide a transition period during which companies are expected to develop and adopt alternatives.
Critical Industrial Uses Could Receive Different Treatment
The European Commission's current policy direction suggests that critical industrial applications may receive different treatment from consumer uses.
In June 2026, Environment Commissioner Jessika Roswall said the Commission is working toward a universal PFAS restriction while considering a ban on PFAS in consumer goods. For industrial applications, continued use could be permitted for critical uses where suitable alternatives are unavailable, subject to strict conditions and until acceptable substitutes are developed.
This could become one of the most important elements of the final regulation.
Rather than a single deadline for every PFAS-containing product, the future framework could contain different compliance pathways depending on:
The application
Availability of alternatives
Technical feasibility of substitution
Socio-economic impact
Environmental emissions
Importance of the application
Time required for transition
Which Industries Could Be Affected?
The potential scope is exceptionally broad because PFAS are used across numerous industries.
The revised assessment specifically examined applications involving:
Electronics and Semiconductors
PFAS can be used in semiconductor manufacturing and other highly controlled production processes. The revised proposal examines how restrictions could affect these applications and whether alternatives can meet demanding technical requirements.
Energy
PFAS-related materials can be relevant to energy technologies and industrial equipment. The revised proposal therefore evaluates the feasibility of substitution in energy applications.
Medical Applications
Medical uses present a particular challenge because material performance and patient safety can be critical.
The revised proposal expanded its assessment to additional medical applications, including immediate packaging and pharmaceutical excipients.
Machinery and Sealing
PFAS-containing materials can provide resistance to heat, chemicals and aggressive operating environments.
The revised proposal therefore specifically examines machinery and sealing applications.
Technical Textiles
Technical textiles represent another area where PFAS properties can provide water, oil or chemical resistance.
The revised proposal assesses whether alternatives are technically and economically feasible.
Refrigerants Are Also Under Scrutiny
PFAS-related restrictions can have implications for refrigeration and air-conditioning applications because several fluorinated substances used as refrigerants fall within the broader PFAS regulatory discussion.
The revised proposal has been examined in detail for different HVAC&R applications, with certain uses receiving different proposed treatment and transition periods depending on the application and availability of alternatives.
This illustrates why the final EU restriction is likely to contain a complicated combination of deadlines, exemptions and conditions rather than a single universal phase-out date.
The Economic Question Is Now Just as Important
The environmental case for reducing PFAS emissions is one part of the regulatory assessment.
The other major question is what a restriction would mean for European industry.
SEAC's work specifically evaluates the socio-economic consequences of restriction options, including costs and the availability of alternatives. The committee's draft opinion was opened to a 60-day consultation in March 2026.
Stakeholders were asked to provide evidence about:
Alternative substances and technologies
Availability of substitutes
Technical feasibility
Economic impacts
Transition requirements
Sector-specific consequences
This information can influence the final design of the restriction.
Companies Are Already Facing a Substitution Challenge
For companies that rely heavily on PFAS, the regulatory process creates a need for long-term planning.
A manufacturer cannot necessarily replace a PFAS-containing material immediately. A substitute may require laboratory testing, production trials, customer approval, certification and changes to equipment.
The process can therefore look like:
Identify PFAS → assess regulatory exposure → identify alternatives → test alternatives → qualify replacement → modify production → phase out PFAS
Companies that wait until a final restriction enters into force could have significantly less time to complete this process.
The Cost of Inaction Is Also Becoming Part of the Debate
The EU is increasingly highlighting the wider economic costs associated with PFAS pollution.
A European Commission-backed study published in January 2026 estimated that continued PFAS pollution at current levels could cost Europe approximately €440 billion by 2050. The study estimated that addressing PFAS releases at their source by 2040 could avoid around €110 billion in costs, while treating contaminated water alone could cost more than €1 trillion.
These figures are part of the broader policy argument for reducing PFAS releases rather than relying solely on remediation after contamination occurs.
What Happens Next?
The next major milestone is the completion of ECHA's scientific evaluation.
SEAC's draft opinion underwent public consultation, while RAC has already adopted its final opinion. ECHA expects SEAC to adopt its final opinion by the end of 2026, after considering relevant information received during consultation.
The process then moves to the European Commission.
The broad sequence is:
ECHA scientific opinions → European Commission restriction proposal → REACH Committee discussion and vote → possible adoption → transition periods and compliance deadlines
Therefore, the final regulatory outcome remains ahead.
What the Revised Proposal Means for Chemical Companies
The revised proposal sends a clear signal to companies using PFAS in Europe: preparation for substitution is becoming increasingly important.
Businesses should consider:
Mapping all PFAS-containing materials and products
Identifying which PFAS are critical to operations
Monitoring proposed derogations
Documenting the availability or absence of alternatives
Assessing supply-chain exposure
Testing potential substitutes
Tracking ECHA and European Commission developments
Preparing for different transition periods
The regulatory discussion is no longer only about whether PFAS will face restrictions. It is increasingly about which uses can transition, how quickly they can transition and what conditions will apply during the transition.
Europe Moves Toward a More Targeted PFAS Phase-Out
The revised proposal marks a significant evolution in the EU's PFAS strategy.
The original concept of a broad restriction remains intact, but the regulatory process is becoming more differentiated. Thousands of stakeholder comments, additional sector assessments and detailed socio-economic analysis have pushed the debate toward targeted derogations and transition arrangements.
ECHA's committees now support EU-wide action with targeted derogations, while the European Commission is preparing for the next stage of the process.
For industry, the key issue is no longer simply whether Europe intends to regulate PFAS. That direction is increasingly clear.
The critical questions are which applications will receive derogations, how long transition periods will last, what conditions will apply and how quickly viable alternatives can be deployed.
Sources
Found this useful?


